Asia-Pacific Journal of Oncology (AJO, Asia Pac J Oncol, p-ISSN: 2708-7980, e-ISSN: 2708-7999) is an open access, international, peer-reviewed journal, published by Asian Medical Press in London, UK. It is published biannually and is openly distributed worldwide. AJO publishes the results of novel research in the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human oncology with the overall goal of improving the clinical care of patients with tumor. It covers some main human tumor types: cerebral tumor, head and neck neoplasm, thoracic neoplasms, breast caner, gastrointestinal cancer, urologic oncology, bone tumour and other any neoplasms types in human.
Editorial board
Editors-in-Chief:
Katarzyna Rygiel (Department of Family Practice, Medical University of Silesia, Zabrze, Poland);
Ning Li (Chief of Physician of Thoracic Surgery, National Cancer Center, Cancer Hospital Chinese Academy of Medical Sciences, China). More >>
Indexing Google Scholar, ResearchGate
Current Issue Volume 5, 2024 >>
Cancer grades among the deadliest diseases, globally causing the death of a over million people each year. Early diagnosis has been considered ideal f ...
Dhahiri Saidi Mashausi, Semukunzi Herve
REVIEW | 14 Jan 2025
In adults, glioblastoma multiforme (GBM) is considered the most widespread and virulent malignancy of the central nervous system (CNS). This formidabl ...
Debanjan Das
REVIEW | 05 Jan 2025
Senescence is irreversible cell cycle arrest that results from therapy-induced stress such as DNA damage. It was initially thought to be a tumor-suppr ...
Qurrat Ul Ain
REVIEW | 29 Dec 2024
The spread of cancer and huge number of cancer related deaths has made it imperative for scientist to search new diagnostic, prognostic and treatment ...
Tayyaba Sona
REVIEW | 27 Dec 2024
One of the most aggressive cancers, pancreatic cancer (PC) frequently has a dismal prognosis. The only known treatment for this illness is surgery, wh ...
Ayesha Fazal Nawaz, Muhammad Arif
REVIEW | 21 Dec 2024
Neuroendocrine breast carcinoma (NEBC), an infrequent malignancy, accounts for 2–5% of all invasive breast cancer cases. The minimal occurrence of the ...
Mohsen S. Ali
REVIEW | 27 Nov 2024